Zhu et al. (54) explored the effect of combinational therapy on breast cancer using a nano carrier called Glycolipid-Based Polymeric Micelles (GLPM) to elucidate how angiotensin II type 1 receptor blockers modulate the tumour microenvironment. This evidence concerns the gene AGTR1 and neoplasm.